|
FAM123B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64002145197628E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
7.17190000054657E-07 |
| Normal-vs-Stage3 |
1.082699999988E-06 |
| Normal-vs-Stage4 |
1.01259999996106E-06 |
| Stage1-vs-Stage2 |
3.851000E-01 |
| Stage1-vs-Stage3 |
5.154500E-02 |
| Stage1-vs-Stage4 |
8.678400E-01 |
| Stage2-vs-Stage3 |
5.773400E-01 |
| Stage2-vs-Stage4 |
5.775800E-01 |
| Stage3-vs-Stage4 |
2.895000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65167879373485E-12 |
| Normal-vs-AfricanAmerican |
5.90759663410267E-11 |
| Normal-vs-Asian |
7.021700E-04 |
| Caucasian-vs-AfricanAmerican |
9.993200E-01 |
| Caucasian-vs-Asian |
7.927800E-01 |
| AfricanAmerican-vs-Asian |
7.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.78820000041169E-07 |
| Male-vs-Female |
3.175700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.01919583883614E-11 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.5187999968802E-08 |
| Normal-vs-Extreme_Obese |
3.96019999999719E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.371800E-01 |
| Normal_Weight-vs-Obese |
1.575810E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.493400E-01 |
| Extreme_Weight-vs-Obese |
2.186200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.259400E-01 |
| Obese-vs-Extreme_Obese |
9.026400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.84080000000298E-05 |
| Normal-vs-Age(41-60Yrs) |
3.3182001590859E-10 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
2.69540001429647E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.135800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.154300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.917900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.220500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.839400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
4.10782519111308E-15 |
| Normal-VS-KIRP CIMP |
6.780900E-03 |
| Normal-VS-Unclassified PRCC |
2.0379999999931E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.915200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.358300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.883800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.694470E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.947800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.707800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.967210E-04 |
| Normal-vs-N2 |
1.610300E-02 |
| N0-vs-N1 |
1.724160E-02 |
| N0-vs-N2 |
4.363400E-01 |
| N1-vs-N2 |
8.867000E-01 |
|
|
